Showing 1951-1960 of 9108 results for "".
Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.Systemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.Legalities of Injecting PDGF: Off-Label or Out-of-Bounds?
https://practicaldermatology.com/issues/october-2025/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/39754/In medicine, science often moves faster than the rules designed to contain it do, and few debates illustrate this tension as starkly as the current one surrounding platelet-derived growth factor (PDGF) injections in aesthetic medicine.Mind the Gap (Year): Being Mindful of Dedicating a Year to Research During Medical School
https://practicaldermatology.com/topics/practice-management/mind-the-gap-year-being-mindful-of-dedicating-a-year-to-research-during-medical-school/23783/A research year can have benefits, but it may not give residency applicants the edge they expect.Dermal Micro-Coring 101
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dermal-micro-coring-101/23376/Expert insight on a new energy-free facelift alternative.Dispatches from the 2022 Skin of Color Update
https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.Journal Club: Combining Dupilumab and Omalizumab
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combining-dupilumab-and-omalizumab/37872/Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, and editorial board member Brad Glick, DO, MPH, FAAD, discuss a recent article about combination therapy with dupilumab and omalizumab for atopic dermatitis. Silva IC, Daher R, Khattri S. Combined use of Omalizumab and dupilumabUnderstanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/programs/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.A Definitive Guide to Recognizing and Treating “Maskne”
https://practicaldermatology.com/columns/clinical-focus-1/a-definitive-guide-to-recognizing-and-treating-maskne/23520/Practical Dermatology® magazine’s resident acne columnist offers step-by-step guidance.Out With the Old, In With the New
https://practicaldermatology.com/topics/psoriasis/out-with-the-old-in-with-the-new-1/23430/A “new” way of assessing psoriasis severity may improve access to care.